These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30782143)

  • 41. Clozapine-olanzapine: a potentially dangerous switch. A report of two cases.
    Delassus-Guenault N; Jegouzo A; Odou P; Seguret T; Zangerlin H; Vignole E; Robert H
    J Clin Pharm Ther; 1999 Jun; 24(3):191-5. PubMed ID: 10438178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
    Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
    Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.
    Hummel B; Dittmann S; Forsthoff A; Matzner N; Amann B; Grunze H
    Neuropsychobiology; 2002; 45 Suppl 1():37-42. PubMed ID: 11893876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report.
    Lin Y; Zhang AD; Sun CF; White JB; Qi A; Farrell JA; Trestman RL; Martin RK; Kablinger AS
    Psychopharmacol Bull; 2022 Jun; 52(3):72-80. PubMed ID: 35815178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder.
    Puri BK; Taylor DG; Alcock ME
    Br J Clin Pract; 1995; 49(6):333-4. PubMed ID: 8554965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clozapine use and abrupt smoking cessation; a potentially life-threatening combination].
    Ruissen A; van Schaik AM; Beijnen JH
    Tijdschr Psychiatr; 2009; 51(9):699-703. PubMed ID: 19760570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Priapism with clozapine therapy].
    Hövermann P; Nürnbach-Ross B; Albrecht J
    Nervenarzt; 1997 Jan; 68(1):74-6. PubMed ID: 9132624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection or idiosyncratic reaction to antiepileptic drugs?
    Presecki P; Grosić V; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):132-4. PubMed ID: 20305610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.
    Stanilla JK; de Leon J; Simpson GM
    J Clin Psychiatry; 1997 Jun; 58(6):252-5. PubMed ID: 9228890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.
    Tollefson GD; Dellva MA; Mattler CA; Kane JM; Wirshing DA; Kinon BJ
    J Clin Psychopharmacol; 1999 Oct; 19(5):435-43. PubMed ID: 10505585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment.
    Mahmood T; Devlin M; Silverstone T
    Aust N Z J Psychiatry; 1997 Jun; 31(3):424-6. PubMed ID: 9226089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
    Seppälä N; Kovio C; Leinonen E
    CNS Drugs; 2005; 19(12):1049-55. PubMed ID: 16332145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catatonia Due to Clozapine Withdrawal: A Case Report and Literature Review.
    Boazak M; Cotes RO; Potvin H; Decker AM; Schwartz AC
    Psychosomatics; 2019; 60(4):421-427. PubMed ID: 30268340
    [No Abstract]   [Full Text] [Related]  

  • 59. Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.
    Wysokiński A; Sobów T
    Nord J Psychiatry; 2016; 70(2):156-60. PubMed ID: 26140393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.